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Summary 
Borrelia burgdo~feri, the spirochetal agent of  Lyme disease, is transmitted by Ixodes ticks. A vac- 
cine based on B. burgdo~feri outer surface protein (Osp) A protects mice from spirochete infec- 
tion. Here we report on the expression of  OspA on spirochetes inside engorging ticks and re- 
late OspA expression to antispirochetal immunity. Spirochetes in the gut of  unfed nymphal 
ticks were stained by an OspA antibody, whereas in feeding ticks, the majority of  spirochetes in
the gut and salivary glands did not stain with the antibody. Thus, OspA was not expressed on 
most spirochetes during transmission from the vector to the vertebrate host. To examine the 
mechanism of  protection afforded by OspA antibody, mice were passively immunized with 
OspA antibody at different imes relative to tick attachment. When OspA antibody was admin- 
istered to mice before or at the time of  tick attachment, spirochetal development events in the 
vector, such as growth and salivary gland invasion, were blocked and the mice were protected 
from B. burgdotferi infection. When OspA antibody was administered to mice 48 h after tick at- 
tachment, spirochetes persisted in the nymphs and the mice were not protected espite the 
presence of  circulating antibodies in the host as well as in the tick blood meal. Thus, OspA im- 
munity appears to be effective only during a narrow window time at the beginning of  the 
blood meal when antibodies bind to OspA-expressing spirochetes in the tick gut and block 
transmission from the vector to the host. 
T he spirochetal agent of  Lyme disease, Borrelia burgdooCeri is transmitted by Ixodes ticks. In unfed nymphal ticks, 
spirochetes are found in the gut (l). During tick feeding, 
the bacteria disseminate to the salivary glands and infect the 
vertebrate host (2-4). A vaccine based on B. burgdo~ri 
outer surface protein (Osp) A which protects mice from in- 
fection is currently being tested in human trials (5-7). Here 
we examine the expression of  OspA on spirochetes within 
engorging nymphs and relate OspA expression to protec- 
tion afforded by OspA antibody. 
Materials and Methods 
Mice. Pathogen-free C3H/HeN (C3H) mice were purchased 
from the National Institutes of Health (Bethesda, MD). 
Maintenance and Infection of Ticks. Ixodes dammini (also known 
as L scapularis) were derived from a colony in its second genera- 
tion from field-collected a ults, and were free of inherited infec- 
tion. Larvae were allowed to engorge on CD-1 mice that had 
been infected 2 wk previously by the bites of three to five 
nymphal I. dammini containing the N40 strain of B. burgdotferi. 
Engorged larvae were collected, held in mesh-covered plaster of 
paris containing vials, and were allowed to molt at 95% relative 
humidity at 21~ The infected nymphs were held under the 
same conditions before their use in experiments, usually within 2 
mo of molting. 
Antibody Staining of OspA-expressing Spirochetes in Nymphal 
Ticks. Guts and salivary glands were dissected out of nymphs 
and prepared for antibody staining as previously described (2). 
mAb CIII.78, which binds to a COOH-terminal protective 
epitope on OspA, was used to assess OspA expression while a rab- 
bit polyclonal antibody raised against the JD-1 strain of B. burgdor- 
fen" was used for visualizing spirochetes. The tissues were imaged 
on a confocal scanning laser microscope (MtLC 600; Bio tkad 
Laboratories, Microscience Division, Cambridge, MA) equipped 
with an argon/krypton laser (2). When examining tick organs for 
spirochetes, the whole organ, including the entire thickness, was 
evaluated for the presence of spirochetes. 
Estimation of Number of Spirochetes Expressing OspA inside 
Ticks. All internal organs were dissected out of infected nymphs 
that had either not fed or fed for 70 h on C3H/HeN mice. Or- 
gans from 10 nymphs were pooled in PBS and the tissues were 
ground using a 1-ml ounce homogenizer (Wheaton Instruments, 
Millville, NJ) to disrupt he tick cells and tissues while causing 
minimal damage to the much smaller spirochetes. From each ho- 
mogenate, a total of four individual 10-1xl drops were placed on 
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silylated glass slides (PGC Scientific, Gaithersburg, MD) and al- 
lowed to air dry. Each slide was dipped in acetone for 5 min be- 
fore staining with an anti-B, burgdo{feri FITC-conjugated rabbit 
polyclonal antibody or polyclonal rabbit sera against OspA or 
OspB. Using a conventional fluorescence microscope, the num- 
ber of spirochetes stained in 10 microscope fields (40• objective) 
was counted in each 10q*l drop. Four such drops were counted 
for each antisera nd the mean number of spirochetes stained in a 
10->1 drop was calculated for each antibody. The antiserum 
against whole spirochetes was used to estimate the total number 
of spirochetes in 10 I*1, while the OspA and OspB antisera were 
used to assess the percentage ofthe total expressing these Osps. 
Evaluation of Mice for B. Burgdotferi Infection and Disease. 2 wk 
after the detachment of ticks, the mice were killed and selected 
tissues (blood, spleen, urinary bladder, ear punch, and skin near 
tick attachment site) were aseptically collected and cultured in 
Barbour-Stoenner-Kelley II media and examined for spirochetes. 
For experiments involving the assessment of disease, knees, tibio- 
tarsi, and hearts were formalin fixed, paraffin embedded, sec- 
tioned, and examined for inflammation. The sections were exam- 
ined blindly and an animal was considered to have arthritis or 
carditis when at least one joint or the heart showed evidence of 
inflammation. 
Results  and Discuss ion 
Although OspA is an abundant protein on B. burgdofferi 
grown in culture, vertebrate hosts infected by tick bite 
rarely seroconvert to OspA (8). Furthermore, once spiro- 
chetes have adapted to the host, they are not vulnerable to 
B. burgdo~ri or OspA antisera (9, 10). OspA may therefore 
be differentially expressed uring the life cycle of  B. burg~ 
dotferi in the tick and vertebrate host. Accordingly, we used 
confocal fluorescence microscopy to examine OspA ex- 
pression on B. burgdo~feri w thin unfed and feeding ticks. 
I. dammini were infected with a clonal population of B. 
burgdo~ri strain N40. Guts and salivary glands were dis- 
sected from unfed nymphs and from ticks removed from 
mice after 60 h of  feeding. Spirochetes were restricted to 
the gut of unfed nymphs, and were labeled with an OspA 
mAb and B. burgdo~eri antiserum, indicating that OspA was 
expressed before tick attachment (Fig. 1, A and/3). During 
tick feeding, the nymphs had many spirochetes in concen- 
trated arrays in the gut, and smaller numbers in the salivary 
glands, which stained with B. burgdo~feri antiserum (Fig. 1, 
C and E) but did not react with the OspA mAb (Fig. 1, D 
and F). A few OspA-labeled spirochetes were observed in 
the guts of  engorged nymphs (data not shown). Thus, 
OspA was readily expressed by B. burgdotferi before tick 
feeding, but the protein was not present in the majority of  
spirochetes during engorgement. 
An estimation of  the proportion of  B. burgdo~feri xpress- 
ing OspA in engorging nymphs was made by directly 
counting spirochetes that bound different antisera. Equal 
aliquots of  tick homogenates were spotted onto glass slides 
and stained with B. burgdo~eri, OspA, or OspB antisera. 
The B. burgdo{feri antiserum reflected the total number of  
spirochetes, whereas the OspA or OspB antisera assessed 
the percentage of  spirochetes expressing these Osps (Fig. 
2). In unfed nymphs, all spirochetes were stained with the 
OspA or OspB antisera (Fig. 2). In contrast, only 30 and 
31% of B. burgdo~eri f om engorging ticks bound the OspA 
or OspB antisera respectively (Fig. 2). The lack of both 
OspA and OspB staining on the majority of  spirochetes 
during tick feeding suggests that expression of  these pro- 
teins may be regulated at the level of  transcription because 
the genes encoding these two antigens are in the same op- 
eron (11). 
The absence of  OspA on the surface of  spirochetes dur- 
ing transmission prompted us to investigate the mechanism 
by which the OspA vaccine protected mice. OspA antise- 
rum was injected into C3H/HeN mice 24 h before placing 
four to seven infected nymphs on each mouse. 60 h after 
attachment, the partially engorged ticks were removed 
from the mice and examined for B. burgdo~ri. 2 wk later, 
the mice were evaluated for infection. Nymphs that fed on 
mice treated with the control (glutathione transferase [GT ]) 
antiserum were heavily infected and spirochetes were 
found in the salivary glands (Table 1). In contrast, only two 
of  seven nymphs that had fed on mice injected with OspA 
antiserum contained a few B. burgdo~feri in the guts. None 
of  these ticks had spirochetes in the salivary glands (Table 
1). Moreover, mice treated with OspA antiserum were 
protected from B. burgdo~ri infection (Table 1). Therefore, 
in the presence of  OspA antiserum, spirochetes in the tick 
gut were destroyed, and replication and salivary gland inva- 
sion, critical parts of  the transmission process, were blocked. 
OspA antiserum primarily protected mice by blocking 
transmission within the vector. 
Table 1. Effect of OspA Antibody on Transmission f
B. Burgdofferi by Nymphal Ticks 
Ticks* Infected tick organs* 
(antisera used for Infection 
murine immunization) Midguts Salivary glands ofmice~ 
Unfed nymphs 3/4 0/4 NA 
Fed nymphs (GT) 6/6 6/6 6/6 
Fed nymphs (GT-OspA) 2/711 0/7 0/6 
* B. burgdotferi N40--infected L dammini ymphs were divided into three 
groups. The first group was set aside as an unfed control group. The 
second group was placed on six C3H/HeN mice (four to seven 
nymphs per mouse) which, 24 h before the placement of ticks, had re- 
ceived a control rabbit antiserum raised against .GT (Fed nymphs, GT). 
The third group of nymphs were placed on C3H/HeN mice (four to 
seven nymphs per mouse), which had received serum from a rabbit im- 
munized with a OspA-GT fusion protein (Fed nymphs, GT-OspA). 
Each mouse received 200p,1 (100 Ixl i.p. and 100 txl s.c.) of the anti- 
serum. 
r Ticks were removed by forceps 60 h after placement, and midguts and 
salivary glands were dissected out and examined for spirochetes by 
staining with a FITC-conjugated rabbit polyclonal antibody raised 
against B. burgdorferi and performing confocal microscopy. 
-~ The mice were killed 2 wk after tick removal and checked for infec- 
tion by attempting to culture spirochetes from blood, spleen, urinary 
bladder, and ear skin near th  tick attachment site. 
II Very few spirochetes w re observed in these two infected midguts. 
NA, not applicable. 
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Figure 1. Confocal fluorescence images of B. burgdooCeri in tick organs stained for OspA expression. (A and B) The same field of a gut from an unfed in- 
fected nymph. (C and D) The same field of a gut from an infected nymph that had fed for 60 h. (E and F) are the same field of a salivary acinus from an 
infected nymph that had fed for 60 h. A, C, and E display the FITC signal from a rabbit serum raised against wholespirochetes, while B, D, and F display 
the Texas red signal from an mAb that binds to OspA. OspA antibody staining was readily detected onspirochetes before tick feeding. During engorge- 
ment, the majority failed tostain with the OspA antibody. Bar, 12.5 p~m. 
Because OspA is differentially expressed during tick 
feeding (Figs. 1 and 2), we assessed B. burgdooCeri transmis- 
sion when OspA antiserum was administered at various 
times during tick engorgement.  Infected nymphs were 
placed on mice and at various times relative to attachment 
(--24, 0, 24, 48, and 72 h) OspA antiserum was passively 
administered to the animals. The nymphs fed to repletion, 
detached from the mice, and 10 d later, they were exam- 
ined by immunof luorescence microscopy for spirochetes. 
B. burgdooCeri were rarely observed in the nymphs recovered 
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Figure 2. OspA and OspB are both not expressed on spirochetes 
within feeding nymphs. To estimate the number of spirochetes that have 
OspA and B on the surface before and during tick feeding, the organs 
were dissected out of infected nymphs that had not fed (10 nymphs) or 
that had fed for 70 h (10 nymphs). Homogenates were prepared from the 
dissected organs and stained with a polyclonal antibody raised against 
whole spirochetes (1), or polyclonal sera raised against OspA (2) or OspB 
(3) to estimate the percentage of spirochetes expressing OspA and OspB. 
from mice given OspA antiserum 24 h before or during 
tick placement (Table 2). When OspA antiserum was ad- 
ministered to mice at the 24-, 48- and 72-h time points, 
spirochetes remained in all nymphs, indicating that the dis- 
appearance of OspA begins between 0 and 24 h after at- 
tachment. Infected nymphs at the 24-h time point had 
low-grade infections (Table 2), suggesting that these ticks 
had a mixture of  B. burgdooCeri, including organisms with 
and without OspA. Selective destruction of  the spirochetes 
expressing OspA may therefore have led to a reduction in 
the overall number of  B. burgdo~feri. At later time points (48 
and 72 h), as more spirochetes failed to express OspA, the 
nymphs remained heavily infected (Table 2). 
B. burgdo~feri were not cultured from mice that were 
treated with OspA antiserum at -24  and 0 h relative to 
tick attachment (Table 2). Mice were protected even when 
antiserum was administered 24 h after attachment, despite a
low level of  spirochete infection within the nymphs (Table 
2). The absence of  host infection at the 24-h time point 
may be caused, in part, by the large decrease in the popula- 
tion of  spirochetes in these nymphs (Table 2). In contrast to 
the 24-h time point, when OspA antiserum was adminis- 
tered 48 and 72 h after tick attachment, all mice became in- 
fected and developed isease (Table 2), suggesting that the 
spirochetes entering mice did not express OspA and were 
unaffected by circulating OspA antibody. 
After nymphal tick attachment, spirochete transmission 
requires ,'~ h, and during this time period, B. burgdogCeri 
multiply and cross the gut epithelial barrier into the hemo- 
lymph, disseminate to the salivary glands, and infect the 
host via tick saliva (2, 3, 12). Our  results document hat 
during tick engorgement, OspA, which is abundantly ex- 
pressed on spirochetes in unfed ticks, is no longer expressed 
on the majority of  B. burgdooCeri in the vector. The loss of  
OspA probably begins ,'~ h after tick attachment, since 
spirochetes resistant to OspA antiserum were first detected 
at this time. The absence of  OspA appears to continue even 
after the spirochetes enter the mammalian host because 
mice were infected when OspA antiserum was adminis- 
tered 48 and 72 h after tick attachment (Table 2). A recent 
report demonstrated that OspC is absent from the spiro- 
chetes in unfed ticks, and is present in feeding ticks and in- 
fected mice (13). During tick engorgement, we observed 
that spirochetes in the gut and salivary glands that do not 
express OspA react with OspC antiserum (data not shown). 
Table 2. Effect of OspA Antibody Administered toMice at Different Times after Tick Attachment 
Antibody* 
(time administered relative to tick placement) 
Infected nymphs* 
(severity of infectionll 
Infection of mice~ 
Culture Disease 
Anti-GT serum (-24 h) 
Anti-GT-OspA serum (-24 h) 
Anti-GT-OspA serum (0 h) 
Anti-GT-OspA serum (24 h) 
Anti-GT-OspA serum (48 h) 
Anti-GT-OspA serum (72 h) 
5/7 (3, heavy; 2, moderate 
0/6 
1/7 (1, low) 
6/6 (6, low) 
9/9 (7, heavy; 2, moderate 
7/7 (2, heavy; 2, moderate; 3, low) 
4/4 3/3 
0/4 0/4 
0/4 0/4 
0/4 0/4 
4/4 4/4 
4/4 4/4 
*Four mice were used in each group and four B. burgdotferi N40-infected I. dammini ymphs were placed on each mouse. The groups of mice were 
infused with 200 txl (100 txl i.p. and 100 Ixl s.c.) of serum from a rabbit immunized w th art OspA-GT fusion protein (GT-OspA) at the indicated 
times before orafter tick attachment. A control rabbit serum raised against GT was used at the -24 h time point. 
* 10 d after detachment, ticks were examined by indirect immunofluorescence microscopy for spirochetes. 
The mice were killed 2 wkafter tick detachment for culture (blood, spleen, urinary bladder, ear, and tick attachment site) and histopathology (eval- 
utation of the joints and hearts for arthritis and/or carditis). 
II To distinguish nymphs with low, moderate and heavy infections the number of spirochetes in 10 (100X objective) microscope fields were counted. 
Nymphs with <20 B. burgdo~eri were characterized as having low, 21-50 as moderate, and 51-200 as heavy infection, respectively. 
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Thus, as spirochetes move from the vector, many appear to 
be "changing their coat" by, at least in part, differential ex- 
pression of  OspA and OspC. During engorgement, em- 
perature shifts and biochemical changes in the tick may di- 
rectly or indirectly influence Osp expression (13, 14). 
The loss of  OspA expression by spirochetes during trans- 
mission has revealed the mechanism by which the OspA 
vaccine protects vertebrate hosts: antibody binds to the 
OspA-expressing B. burgdo~feri in the tick gut and prevents 
their replication and subsequent dissemination to the sali- 
vary glands and, ultimately, to the vertebrate host. This is 
the first example of  a vaccine undergoing human clinical 
trims that protects by blocking transmission from the vec- 
tor. Approximately 24 h after tick attachment, some of  the 
spirochetes in the vector become resistant to vaccine- 
induced OspA immunity, probably because they no longer 
express OspA on their surface. By 48 h after tick engorge- 
ment, B. burgdooCeri that had entered mice were fully resis- 
tant to OspA antiserum. Thus, the OspA vaccine is likely 
to be effective only during a narrow window of  24 h after 
tick attachment, when OspA antibody comes into contact 
with OspA-expressing spirochetes in the tick gut. 
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